In bladder cancer, MAGI2-AS3 operates through a ceRNA mechanism involving the MAGI2-AS3/miR-31–5p/TNS1 axis, with its downregulation linked to increased migration, proliferation, and invasion, emphasizing its role in metastasis and tumor staging (Table 1) (80). The gene discussed is MAGI2; the disease is urinary bladder cancer.